News Archive

Lesley Curtis, PhD, member in the Duke Clinical Research Institute (DCRI), chief of the Department of Population Health Sciences and professor in the Duke School of Medicine Departments of Population Health Sciences and Medicine was selected to receive the QCOR Outstanding Lifetime Achievement Award by the American Heart Association’s Council on Quality of Care and Outcomes Research (QCOR).

The DCRI was represented in poster sessions, moderated digital poster sessions, debates, simulations, learning labs and main stage presentations.

Researchers from the Duke Clinical Research Institute (DCRI) were once again named to Clarivate's Most Highly Cited Scientists list.

By randomizing 10,000 adult patients, ARTEMIS will evaluate the effects of a study medicine versus placebo on cardiovascular outcomes in patients with acute myocardial infarction.

An antibiotic that has shown effectiveness for bacterial pneumonia also appears successful in fighting methicillin-resistant staph infections, reports a team led by Duke Health.

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
(IPF/ILD-PRO)

When it comes to COVID-19 testing and vaccination, not all Hispanic populations respond the same.

Explore how the integration of digital tools and consumer-oriented approaches in clinical trials can enhance participant diversity and recruitment efficiency while addressing challenges in equity, ethics, and security.

Sept. 28, 2023 — Cardiovascular disease is the number one killer of people in the United States and worldwide.

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no clinical benefit to taking fluticasone furoate for treatment of mild-to-moderate COVID-19 symptoms.